MedTrace Logo

Monocentric Feasibility Study for a New Medical Device for the Treatment of Anal Fissure With Botulinum Toxin

NCT04173130 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2020-11-17

No results posted yet for this study

Summary

Monocentric feasibility study for a new device for the treatment of anal fissure with botulinum toxin.

Conditions

  • Anal Fissure

Interventions

DEVICE

Anuscope with needles

Injection of botulinum toxin into the anal sphincter with the investigational device (anuscope with needles).

Sponsors & Collaborators

  • Dieter Hahnloser

    lead OTHER

Principal Investigators

  • Dieter Hahnloser, Prof. · Lausanne Universitaire Hospital (CHUV)

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-11
Primary Completion
2020-11-13
Completion
2020-11-13

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04173130 on ClinicalTrials.gov